Log In

Forgot Password?
Create New Account

Loading... please wait

2022 Annual Meeting | C99 - Neurologic Complications of Novel Anti-neoplastic Therapies Including Immunotherapy

Tuesday 04/05/22
01:00 PM - 03:00 PM PDT Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Yazmin Odia, MD, MS, FAAN
Neuro-oncology
Participants should become familiar with the distinct types of anti-neoplastic therapies, including cytotoxic, biologic, hormone, immunotherapy, radiation and other multimodal therapies, and their unique neurological complications, as well as understand the underlying mechanisms of actions, interpret clinical and radiographic manifestations, and manage the neurological toxicities relative to the distinct types of anti-neoplastic therapies.
2.00 CME credits
Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement
Intermediate
Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student
Didactic

Program Materials Program Evaluations

Event Timeline
01:00 PM - 01:05 PM PDT Introduction Introduction to Course and Novel Cancer Therapies
Yazmin Odia, MD, MS, FAAN
01:00 PM - 01:00 PM PDT Speaker Walk-in Slides
Yazmin Odia, MD, MS, FAAN
01:05 PM - 01:40 PM PDT Speaker Complications of Cytotoxic, Biologic, and Hormone Therapies
Ekokobe Fonkem, DO
01:40 PM - 02:15 PM PDT Speaker Complications of Immunotherapies
Reena P. Thomas, MD, PhD
02:15 PM - 03:50 PM PDT Speaker Complications of Radiation and Multimodal Therapies
Yazmin Odia, MD, MS, FAAN
03:50 PM - 04:00 PM PDT Q&A Panel Discussion
Yazmin Odia, MD, MS, FAAN, Reena P. Thomas, MD, PhD, Ekokobe Fonkem, DO
Faculty Disclosures
Yazmin Odia, MD, MS, FAAN Dr. Odia has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for PharPoint. Dr. Odia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GammaTile.
Reena P. Thomas, MD, PhD The institution of Dr. Thomas has received research support from NIH. The institution of Dr. Thomas has received research support from Health Resources & Services Administration. The institution of Dr. Thomas has received research support from California Institute of Regenerative Medicine. Dr. Thomas has received intellectual property interests from a discovery or technology relating to health care.
Ekokobe Fonkem, DO Dr. Fonkem has received personal compensation for serving as an employee of Barrow Neurological Institute. Dr. Fonkem has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Fonkem has stock in Global Cancer Technology.